ArticleEnvironmental science & technology2025
Toxicokinetic Profiling and Developmental Toxicity of Long-Chain Per- and Polyfluoroalkyl Substances in Zebrafish.
Article in Environmental science & technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Perfluorooctanesulfonate (PFOS), perfluorodecanoic acid (PFDA), and perfluoroundecanoic acid (PFUnA) are three legacy long-chain per-/polyfluoroalkyl substances (PFAS). Although phased out of production, recent studies indicate substantial exposure can occur through consumption of contaminated freshwater fish, with minimal information known on the potential for developmental toxicity, especially for PFDA and PFUnA. In this study, zebrafish were used to characterize the toxicokinetics of these three PFAS as a model for developmental neurotoxicity, specifically behavior and dopamine (DA) dysregulation. Mass spectrometer quantification of water and tissue samples revealed that all three PFAS were rapidly absorbed during the early developmental window and bioconcentrated in tissue to a substantial degree. The visual motor response assay revealed altered behavioral patterns in the larvae, especially for PFDA and PFUnA. Enzyme-linked immunosorbent assay (ELISA) quantification of DA indicated these compounds induced elevations in total DA at nearly every exposure concentration for each compound down to the lowest test concentration used in this study at 0.004 ppb (ppb, μg/L) (equivalent to 4 ppb, US EPA drinking water regulation for PFOS). These findings confirm that PFOS, PFDA, and PFUnA exhibit a substantial capacity for bioaccumulation and demonstrate a need for further research into how developmental exposure impacts neurological health.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.